evolocumab
amgen
['fourier']
as we recently published with : no safety issue with low #ldl, further ischemic reduction (cv mortality) with longer follow up as time exposure under #llt matters +++ #fourierole #esccongress 
President of CNCF. Member of the ACTION-Group. Associate Editor at Minerva Cardio-Angiology+Archives Med.Science-Scientific Director atAxis TV. tweets on my own